A striking property of recombinant poxviruses: Efficient inducers of in vivo expansion of primed CD8+ T cells

Virology

Volumn 280, Issue 2, 2001, Pages 155-159

  Zavala, Fidel ^a   Rodrigues, Mauricio ^b   Rodriguez, Dolores ^c   Rodriguez, Juan Ramón ^c   Nussenzweig, Ruth S ^a   Esteban, Mariano ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; VIRUS VACCINE; VIRUS VECTOR;

CELLULAR IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IN VIVO STUDY; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE; VIRUS RECOMBINANT; VIRUS REPLICATION;

POXVIRIDAE;

EID: 0035866326     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0792     Document Type: Article

References (35)

1. Viral mechanisms of immune evasion
2. Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization
3. Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: Implications for use as human vaccine
4. + T cell immunogenicity and protective efficacy in the influenza and malaria models
5. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 env in a dose-dependent manner
6. A protein particle vaccine containing multiple malaria epitopes
7. Enhanced cellular immune response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants
8. Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime
9. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen
10. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus
11. + T-cell-mediated protective immunity against malaria
12. Production of recombinant subunit vaccines: Protein immunogens, live delivery systems and nucleic acid vaccines
13. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection
14. The smallpox vaccination strain MVA: Marker, genetic structure, experience gained with the parenteral vaccination and behaviour in organisms with a debilitated defence mechanism
15. Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence
16. + T cell responses in mice
17. Genetically engineered poxviruses for recombinant gene expression, vaccination and safety
18. Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates
19. In vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses: Characterization and quantitative analysis
20. Immunogenicity of Ty-virus like particles bearing a CD8+ T cell epitope of the CS protein of Plasmodium yoelii
21. A pilot phase II study of the safety and immunogenicity of HIV p17/p24: VLP (p24-VLP) in asymptomatic HIV seropositive subjects
22. Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use
23. st century
24. The prime-boost strategy: Exciting prospects for improved vaccination
25. Neutralizing antibody-independent containment of immunodeficiency virus challenged by DNA priming and recombinant poxvirus booster immunizations
26. Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell mediated immunity against malaria
27. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes: Comparison of their immunogenicity and capacity to induce protective immunity
28. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
29. Induction of CD8+ T cells using heterolegeus prime-boost immunization strategies
30. Boosting with recombinant vaccinia virus increases the immunegenicity and protective efficacy of malaria DNA vaccines
31. Nonreplicating vaccinia vector efficiently expresses recombinant genes
32. A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus
33. Recombinant Sindbis viruses expressing a cytotoxic T lymphocyte epitope of a malaria parasite or of an influenza virus elicit protection against the corresponding pathogen in mice
34. Immunogenicity of the yeast recombinant p17/p24: Ty-virus-like particles (p24-VLP) in health volunteers
35. Visualization, characterization and turnover of CD8+ memory T cells in virus-infected hosts